TXT
63
4
DNB
40
-4
IVZ
66
-2
AVGO
40
-2
WEC
53
-2
SLG
34
-3
UA
1
-2
BDX
63
-2
TAP
54
-2
JBHT
32
-3
CSX
48
9
CPB
30
-4
PAYX
32
-6
ALL
64
-2
WBA
29
-2
VNO
36
-2
WYNN
33
5
ADT
53
-5
MRK
45
-3
PPG
41
-2
TXT
63
4
DNB
40
-4
IVZ
66
-2
AVGO
40
-2
WEC
53
-2
SLG
34
-3
UA
1
-2
BDX
63
-2
TAP
54
-2
JBHT
32
-3
CSX
48
9
CPB
30
-4
PAYX
32
-6
ALL
64
-2
WBA
29
-2
VNO
36
-2
WYNN
33
5
ADT
53
-5
MRK
45
-3
PPG
41
-2
Financhill
Back

First Trust NASDAQ Technology Dividend Index Fund Vs. Nektar Therapeutics Industry Stock Comparison

Sell
44

TDIV
First Trust NASDAQ Technology Dividend Index Fund

Last Price:
$92.44
Seasonality Move:
1.23%
Sell
49

NKTR
Nektar Therapeutics

Last Price:
$23.48
Seasonality Move:
4.65%
Sell
44
First Trust NASDAQ Technology Dividend Index Fund (TDIV) is a Sell

Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?

  • The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $90.65. The Score for TDIV is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • TDIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $22.47. The Score for NKTR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TDIV Stock Price Chart

What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?

  • The First Trust NASDAQ Technology Dividend Index Fund share price today is $90.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDIV is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $22.47
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

TDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 24.92 Buy
Relative Strength Index (14 RSI): 51.81 Buy
Chaikin Money Flow: -49190 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.57 - 92.13) Sell
Bollinger Bands (100): (73.68 - 90.2) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 50.35 Buy
Chaikin Money Flow: -402319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.47 - 24.95) Sell
Bollinger Bands (100): (8.1 - 21.84) Buy

TDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.42 Buy
20-day SMA: 91.22 Sell
50-day SMA: 89.12 Buy
200-day SMA: 80.95 Buy
8-day EMA: 83.3 Buy
20-day EMA: 57.34 Buy
50-day EMA: 29.9 Buy
200-day EMA: 8.63 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.53 Sell
20-day SMA: 23.61 Sell
50-day SMA: 19.66 Buy
200-day SMA: 15 Buy
8-day EMA: 22.69 Sell
20-day EMA: 22.83 Sell
50-day EMA: 20.33 Buy
200-day EMA: 16.25 Buy

First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.

First Trust NASDAQ Technology Dividend Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):